Retrospective Study of Adherence to Glucagon-like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes Mellitus in the United States

被引:0
作者
Stephen S. Johnston
Hiep Nguyen
Eugene Felber
Katherine Cappell
James K. Nelson
Bong-Chul Chu
Iftekhar Kalsekar
机构
[1] Truven Health Analytics,
[2] AstraZeneca,undefined
[3] Bristol-Myers Squibb,undefined
[4] Truven Health Analytics,undefined
[5] Truven Health Analytics,undefined
来源
Advances in Therapy | 2014年 / 31卷
关键词
Adherence; Glucagon-like peptide-1 receptor agonist; Type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1119 / 1133
页数:14
相关论文
共 100 条
  • [1] Tamez-Pérez HE(2013)Standards of medical care in diabetes—2013 Diabetes Care 36 S11-S66
  • [2] Proskauer-Peña SL(2013)AACE comprehensive diabetes management algorithm 2013 Endocr Pract 19 736-737
  • [3] Hernŕndez-Coria MI(2011)A review of diabetes treatment adherence and the association with clinical and economic outcomes Clin Ther 33 74-109
  • [4] Garber AJ(2012)The economic rationale for adherence in the treatment of type 2 diabetes mellitus Am J Manag Care 18 S43-S48
  • [5] Asche C(2009)Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature Value Health 12 915-922
  • [6] LaFleur J(2005)Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus Am J Med 118 27S-34S
  • [7] Conner C(2011)Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes J Med Econ 14 562-567
  • [8] Wild H(2008)The impact of medication regimen factors on adherence to chronic treatment: a review of literature J Behav Med 31 213-224
  • [9] Salas M(2002)Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy Clin Ther 24 460-467
  • [10] Hughes D(2010)Impact of treatment complexity on adherence and glycemic control: an analysis of oral antidiabetic agents J Clin Outcomes Manag 17 257-265